Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GlaxoSmithKline Pulls Tykerb sNDA Ahead Of FDA Panel Review

Related Content

Tykerb/Herceptin Combination Will Go Before FDA Advisory Panel

May 30 2012

GSK Study Shows Tykerb/Herceptin Combo Increases Progression-Free Survival In Breast Cancer

May 16 2008

Related Companies

GSK plc

Roche Holding AG

Genentech, Inc.

Additional Topics

United States Advisory Committees BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window